Faron Pharmaceuticals Oy (GB:FARN) has released an update. Faron Pharmaceuticals has filed a patent application for the use of soluble Clever-1 in inactivating T-cells, a development poised to expand ...

“To improve usability in hospitals, as well as to prevent DNA and RNA contamination in laboratory settings, we need to think not only about inactivating microorganisms and viruses, but about ...

Identification of six cancer susceptibility genes offers new insights into genetic risk factors, potentially enhancing early ...

New research has revealed that even asymptomatic people carry the avian flu virus, suggesting that infections among dairy ...

The lawsuit alleges Oregon and Secretary of State Lavonne Griffin-Valade have failed to remove inactive voters from ...

If it’s the ballot of someone who no longer lives at that address, or even in the state, clerks will try to send them a ...

TURKU, FINLAND - Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company focused on tackling cancers and inflammation via novel immunotherapies, today ...

Many people experience a mild tingling or burning sensation when eating pineapple. This is due to bromelain, an enzyme that ...

This important study explores the interplay between gene dosage and gene mutations in the evolution of antibiotic resistance. The authors provide solid evidence to connect proteostasis with gene ...

The Los Angeles-class nuclear-powered attack submarine, also known as SSN-725 whose motto is “Proud and Fearless,” was listed ...

Adding, changing or inactivating PrP genes in normal mice creates genetically engineered mice called transgenic mice. Hamster prions can not infect normal mice but they can infect transgenic mice ...